Active Targeted Macrophage-Mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson?s Disease

Journal of Nanomedicine & Nanotechnology
doi 10.4172/2157-7439.s4-003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Intranasal Delivery of Rotigotine to the Brain With Lactoferrin-Modified PEG-PLGA Nanoparticles for Parkinson’s Disease Treatment

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2016English

Delivery of Molecularly Targeted Therapy to Malignant Glioma, a Disease of the Whole Brain

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2011English

Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2013English

Electroconvulsive Therapy in Parkinson´s Disease

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2015English

Targeted Delivery of Doxorubicin to HER2 Positive Tumor Models

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

Depression in Parkinson’s Disease

Journal of Parkinsonism and Restless Legs Syndrome
2012English

Acute Administration of Catalase Targeted to ICAM-1 Attenuates Neuropathology in Experimental Traumatic Brain Injury

Scientific Reports
Multidisciplinary
2017English

Spatial Updating in Parkinson′s Disease

Brain and Cognition
DevelopmentalArtsCognitive PsychologyNeuropsychologyEducational PsychologyHumanitiesCognitive NeurosciencePhysiological PsychologyExperimental
1993English

Neuronal Pathology in Parkinson?s Disease

Cell and Tissue Research
Forensic MedicinePathologyHistologyCell Biology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy